Product Code: GVR-4-68041-012-6
Patient Centric Healthcare App Market Summary
The global patient centric healthcare app market size was valued at USD 17.4 billion in 2025 and is projected to grow from USD 20.7 billion in 2026 to USD 64.7 billion by 2033, at a CAGR of 17.7% from 2025 to 2033. North America dominated the market, accounting for the largest revenue share of 42.7% in 2025. Increasing demand for convenient access to personal health information, rising adoption of digital health services, and growing emphasis on patient engagement and self-management are expected to drive the growth of the market over the forecast period.
Moreover, rising smartphone usage, enhanced connectivity across healthcare information systems, increasing demand for continuous disease management, and growing preference for personalized digital healthcare services are further contributing to market growth.
Global Patient Centric Healthcare App Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on industry trends in each of the segments from 2021 to 2033. For the purpose of this study, Grand View Research, Inc. has segmented the global patient centric healthcare apps market report on the basis of type, platform, revenue model, end-use, and region:
- Type Outlook (Revenue, USD Million, 2021 - 2033)
- Healthcare Access & Appointment Management Apps
- Telehealth & Virtual Consultation Apps
- Patient Health Record & Information Apps
- Medication & Prescription Management Apps
- Disease & Treatment Management Apps
- Remote Patient Monitoring Apps
- Patient Communication & Care Coordination Apps
- Health Insurance & Payment Management Apps
- Patient Education & Treatment Support Apps
- Other Patient-Centric Healthcare Apps
- Platform Outlook (Revenue, USD Million, 2021 - 2033)
- Android
- iOS
- Web / Progressive Web Application
- Revenue Model Outlook (Revenue, USD Million, 2021 - 2033)
- Subscription
- Enterprise Licensing
- Per-Patient / Per-Use Fees
- Advertising & Sponsorship
- Other Revenue Models
- End-use Outlook (Revenue, USD Million, 2021 - 2033)
- Patients (Self-Use)
- Healthcare Providers
- Healthcare Payers
- Pharmaceutical & MedTech Companies
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- Europe
- Germany
- UK
- Spain
- Italy
- France
- Denmark
- Norway
- Sweden
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database.
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Patient Centric Healthcare Apps Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.3. Patient Centric Healthcare Apps Market Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTLE Analysis
- 3.4. Case Study Analysis
- 3.5. Emerging Technological Trends in the Patient Centric App Market
- 3.6. Patient-Centric Healthcare App White Space Analysis
- 3.7. Patient Engagement Ecosystem Analysis
- 3.8. Patient Engagement Capability Maturity Assessment
- 3.9. Patient Journey Digitalization Analysis
Chapter 4. Patient Centric Healthcare Apps Market: Type Estimates & Trend Analysis
- 4.1. Definition and Scope
- 4.2. Type Market Share, 2025 & 2033
- 4.3. Segment Dashboard
- 4.4. Global Patient Centric Healthcare Apps Market by Type Outlook
- 4.4.1. Telehealth & Virtual Consultation Apps
- 4.4.1.1. Telehealth & Virtual Consultation Apps Market Estimates and Forecast, 2021 to 2033 (USD Million)
- 4.4.2. Disease & Treatment Management Apps
- 4.4.2.1. Disease & Treatment Management Apps Market Estimates and Forecast, 2021 to 2033 (USD Million)
- 4.4.3. Healthcare Access & Appointment Management Apps
- 4.4.3.1. Healthcare Access & Appointment Management Apps Market Estimates and Forecast, 2021 to 2033 (USD Million)
- 4.4.4. Patient Health Record & Information Apps
- 4.4.4.1. Patient Health Record & Information Apps Market Estimates and Forecast, 2021 to 2033 (USD Million)
- 4.4.5. Medication & Prescription Management Apps
- 4.4.5.1. Medication & Prescription Management Apps Market Estimates and Forecast, 2021 to 2033 (USD Million)
- 4.4.6. Remote Patient Monitoring Apps
- 4.4.6.1. Remote Patient Monitoring Apps Market Estimates and Forecast, 2021 to 2033 (USD Million)
- 4.4.7. Patient Communication & Care Coordination Apps
- 4.4.7.1. Patient Communication & Care Coordination Apps Market Estimates and Forecast, 2021 to 2033 (USD Million)
- 4.4.8. Patient Education & Treatment Support Apps
- 4.4.8.1. Patient Education & Treatment Support Apps Market Estimates and Forecast, 2021 to 2033 (USD Million)
- 4.4.9. Health Insurance & Payment Management Apps
- 4.4.9.1. Health Insurance & Payment Management Apps Market Estimates and Forecast, 2021 to 2033 (USD Million)
- 4.4.10. Other Patient-Centric Healthcare Apps
- 4.4.10.1. Other Patient-Centric Healthcare Apps Market Estimates and Forecast, 2021 to 2033 (USD Million)
Chapter 5. Patient Centric Healthcare Apps Market: Platform Estimates & Trend Analysis
- 5.1. Definition and Scope
- 5.2. Platform Market Share, 2025 & 2033
- 5.3. Segment Dashboard
- 5.4. Global Patient Centric Healthcare Apps Market by Platform Outlook
- 5.4.1. Android
- 5.4.1.1. Android Market Estimates and Forecast, 2021 to 2033 (USD Million)
- 5.4.2. iOS
- 5.4.2.1. iOS Market estimates and forecast, 2021 to 2033 (USD Million)
- 5.4.3. Web / Progressive Web Application
- 5.4.3.1. Web / Progressive Web Application Market Estimates and Forecast, 2021 to 2033 (USD Million)
Chapter 6. Patient Centric Healthcare Apps Market: Revenue Model Estimates & Trend Analysis
- 6.1. Definition and Scope
- 6.2. Revenue Model Market Share, 2025 & 2033
- 6.3. Segment Dashboard
- 6.4. Global Patient Centric Healthcare Apps Market by Revenue Model Outlook
- 6.4.1. Subscription
- 6.4.1.1. Subscription Market Estimates and Forecast, 2021 to 2033 (USD Million)
- 6.4.2. Enterprise Licensing
- 6.4.2.1. Enterprise Licensing Market Estimates and Forecast, 2021 to 2033 (USD Million)
- 6.4.3. Per-Patient / Per-Use Fees
- 6.4.3.1. Per-Patient / Per-Use Fees Market Estimates and Forecast, 2021 to 2033 (USD Million)
- 6.4.4. Advertising & Sponsorship
- 6.4.4.1. Advertising & Sponsorship Market Estimates and Forecast, 2021 to 2033 (USD Million)
- 6.4.5. Other Revenue Models
- 6.4.5.1. Other Revenue Models Market Estimates and Forecast, 2021 to 2033 (USD Million)
Chapter 7. Patient Centric Healthcare Apps Market: End Use Estimates & Trend Analysis
- 7.1. Definition and Scope
- 7.2. End Use Market Share, 2025 & 2033
- 7.3. Segment Dashboard
- 7.4. Global Patient Centric Healthcare Apps Market by End Use Outlook
- 7.4.1. Patients (Self-Use)
- 7.4.1.1. Patients (Self-Use) Market Estimates and Forecast, 2021 to 2033 (USD Million)
- 7.4.2. Healthcare Providers
- 7.4.2.1. Healthcare Providers Market Estimates and Forecast, 2021 to 2033 (USD Million)
- 7.4.3. Healthcare Payers
- 7.4.3.1. Healthcare Payers Market Estimates and Forecast, 2021 to 2033 (USD Million)
- 7.4.4. Pharmaceutical & MedTech Companies
- 7.4.4.1. Pharmaceutical & MedTech Companies Market Estimates and Forecast, 2021 to 2033 (USD Million)
Chapter 8. Patient Centric Healthcare Apps Market: Regional Estimates & Trend Analysis, By Type, By Platform, By Revenue Model, By End Use
- 8.1. Regional Market Share Analysis, 2025 & 2033
- 8.2. Regional Market Dashboard
- 8.3. Global Regional Market Snapshot
- 8.4. North America
- 8.4.1. U.S.
- 8.4.1.1. Key country dynamics
- 8.4.1.2. Regulatory framework
- 8.4.1.3. Competitive scenario
- 8.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.2. Canada
- 8.4.2.1. Key country dynamics
- 8.4.2.2. Regulatory framework
- 8.4.2.3. Competitive scenario
- 8.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.3. Mexico
- 8.4.3.1. Key country dynamics
- 8.4.3.2. Regulatory framework
- 8.4.3.3. Competitive scenario
- 8.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5. Europe
- 8.5.1. UK
- 8.5.1.1. Key country dynamics
- 8.5.1.2. Regulatory framework
- 8.5.1.3. Competitive scenario
- 8.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.2. Germany
- 8.5.2.1. Key country dynamics
- 8.5.2.2. Regulatory framework
- 8.5.2.3. Competitive scenario
- 8.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.3. France
- 8.5.3.1. Key country dynamics
- 8.5.3.2. Regulatory framework
- 8.5.3.3. Competitive scenario
- 8.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.4. Italy
- 8.5.4.1. Key country dynamics
- 8.5.4.2. Regulatory framework
- 8.5.4.3. Competitive scenario
- 8.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.5. Spain
- 8.5.5.1. Key country dynamics
- 8.5.5.2. Regulatory framework
- 8.5.5.3. Competitive scenario
- 8.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.6. Norway
- 8.5.6.1. Key country dynamics
- 8.5.6.2. Regulatory framework
- 8.5.6.3. Competitive scenario
- 8.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.7. Sweden
- 8.5.7.1. Key country dynamics
- 8.5.7.2. Regulatory framework
- 8.5.7.3. Competitive scenario
- 8.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.8. Denmark
- 8.5.8.1. Key country dynamics
- 8.5.8.2. Regulatory framework
- 8.5.8.3. Competitive scenario
- 8.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6. Asia Pacific
- 8.6.1. Japan
- 8.6.1.1. Key country dynamics
- 8.6.1.2. Regulatory framework
- 8.6.1.3. Competitive scenario
- 8.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.2. China
- 8.6.2.1. Key country dynamics
- 8.6.2.2. Regulatory framework
- 8.6.2.3. Competitive scenario
- 8.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.3. India
- 8.6.3.1. Key country dynamics
- 8.6.3.2. Regulatory framework
- 8.6.3.3. Competitive scenario
- 8.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.4. Australia
- 8.6.4.1. Key country dynamics
- 8.6.4.2. Regulatory framework
- 8.6.4.3. Competitive scenario
- 8.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.5. South Korea
- 8.6.5.1. Key country dynamics
- 8.6.5.2. Regulatory framework
- 8.6.5.3. Competitive scenario
- 8.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.6. Thailand
- 8.6.6.1. Key country dynamics
- 8.6.6.2. Regulatory framework
- 8.6.6.3. Competitive scenario
- 8.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7. Latin America
- 8.7.1. Brazil
- 8.7.1.1. Key country dynamics
- 8.7.1.2. Regulatory framework
- 8.7.1.3. Competitive scenario
- 8.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.2. Argentina
- 8.7.2.1. Key country dynamics
- 8.7.2.2. Regulatory framework
- 8.7.2.3. Competitive scenario
- 8.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8. Middle East and Africa
- 8.8.1. South Africa
- 8.8.1.1. Key country dynamics
- 8.8.1.2. Regulatory framework
- 8.8.1.3. Competitive scenario
- 8.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.2. Saudi Arabia
- 8.8.2.1. Key country dynamics
- 8.8.2.2. Regulatory framework
- 8.8.2.3. Competitive scenario
- 8.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.3. UAE
- 8.8.3.1. Key country dynamics
- 8.8.3.2. Regulatory framework
- 8.8.3.3. Competitive scenario
- 8.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.4. Kuwait
- 8.8.4.1. Key country dynamics
- 8.8.4.2. Regulatory framework
- 8.8.4.3. Competitive scenario
- 8.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.3. Key company market position analysis, 2025
- 9.3.1. Epic Systems Corporation
- 9.3.1.1. Company overview
- 9.3.1.2. Financial performance
- 9.3.1.3. Service benchmarking
- 9.3.1.4. Strategic initiatives
- 9.3.2. Teladoc Health, Inc.
- 9.3.2.1. Company overview
- 9.3.2.2. Financial performance
- 9.3.2.3. Service benchmarking
- 9.3.2.4. Strategic initiatives
- 9.3.3. Medisafe
- 9.3.3.1. Company overview
- 9.3.3.2. Financial performance
- 9.3.3.3. Service benchmarking
- 9.3.3.4. Strategic initiatives
- 9.3.4. Ada Health GmbH
- 9.3.4.1. Company overview
- 9.3.4.2. Financial performance
- 9.3.4.3. Service benchmarking
- 9.3.4.4. Strategic initiatives
- 9.3.5. Healthily LTD
- 9.3.5.1. Company overview
- 9.3.5.2. Financial performance
- 9.3.5.3. Service benchmarking
- 9.3.5.4. Strategic initiatives
- 9.3.6. Medadvisor Solutions
- 9.3.6.1. Company overview
- 9.3.6.2. Financial performance
- 9.3.6.3. Service benchmarking
- 9.3.6.4. Strategic initiatives
- 9.3.7. Google
- 9.3.7.1. Company overview
- 9.3.7.2. Financial performance
- 9.3.7.3. Service benchmarking
- 9.3.7.4. Strategic initiatives
- 9.3.8. Apple Inc.
- 9.3.8.1. Company overview
- 9.3.8.2. Financial performance
- 9.3.8.3. Service benchmarking
- 9.3.8.4. Strategic initiatives
- 9.3.9. SAMSUNG
- 9.3.9.1. Company overview
- 9.3.9.2. Financial performance
- 9.3.9.3. Service benchmarking
- 9.3.9.4. Strategic initiatives
- 9.3.10. Doctolib
- 9.3.10.1. Company overview
- 9.3.10.2. Financial performance
- 9.3.10.3. Service benchmarking
- 9.3.10.4. Strategic initiatives